StemRIM Inc.

4599

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

NEWUpdated: 2026-09-09FY2026

Revenue

YoY -

Operating Income

-20100M JPY

YoY -1.4%

Net Income

-18.5100M JPY

YoY +4.0%

EPS

-29.6JPY

YoY +4.9%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

23.5億円

12.4億円

1.4億円

-9.7億円

-20.8億円

Rev: 22百万円Op: -19.8億円NI: -19.5億円

Rev: 23.5億円Op: 1.4億円NI: 1.7億円

Rev: -Op: -20.8億円NI: -20.2億円

Rev: -Op: -19.7億円NI: -19.3億円

Rev: -Op: -20億円NI: -18.5億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Achievement

FY2026

Net Income-

Revenue Progress-

Revenue Forecast-

Net Income Achieved-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan